70539-001 : Tymlos 2000 ug/ml Subcutaneous Injection, Solution
NDC: | 70539-001 |
Labeler: | Radius Health, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Tymlos |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | NDA208743 |
Rev. Date: |
NDC Package Codes:
- 70539-001-02: 1 CARTRIDGE IN 1 BOX, UNIT‑DOSE (70539‑001‑02) > 1.56 ML IN 1 CARTRIDGE (70539‑001‑01)
- 70539-001-98: 1 CARTRIDGE IN 1 BOX, UNIT‑DOSE (70539‑001‑98) > 1.56 ML IN 1 CARTRIDGE (70539‑001‑99)
Active Ingredients:
- Abaloparatide
Dosage Strength:
- 2000 ug/mL
Pharmaceutical Classes:
- Parathyroid Hormone-Related Peptide Analog [EPC]
- Parathyroid Hormone-Related Protein [CS]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 70538-450Next: 70539-400 >
Related Discussions:
Tymlos and Blood Sugar
I have been on Tymlos for 12 months. Over the last few months I am having problems with high blood sugars and a high A1C... 4 replies
I have been on Tymlos for 12 months. Over the last few months I am having problems with high blood sugars and a high A1C... 4 replies
Tymlos - the new approved drug
I have been prescribed Tymlos but my insurance denied me. I'm in the appeal process and my dr. says we could start R... 4 replies
I have been prescribed Tymlos but my insurance denied me. I'm in the appeal process and my dr. says we could start R... 4 replies
Cost and Efficacy of Tymlos
Does anyone have coverage for Tymlos? Is there any way to be able to afford the cost? Has anyone felt they have benefite... 1 reply
Does anyone have coverage for Tymlos? Is there any way to be able to afford the cost? Has anyone felt they have benefite... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.